Condition: Congenital Adrenal Hyperplasia · Sponsor: H. Lundbeck A/S
This trial will evaluate the effects of different doses of Lu AG13909 in adult participants with congenital adrenal hyperplasia, also called CAH. CAH is a rare genetic disorder that affects a person's ability to produce certain hormones. The main goals of this trial are to learn about the safety and tolerability of Lu AG13909, how Lu AG13909 behaves in the body, and how the body responds to Lu AG13909.
This description comes directly from the study's public registry record.
Email contact via H. Lundbeck A/S · +45 36301311 · HQ_Medinfo@Lundbeck.com
Always discuss trial participation with your own doctor first.
| University Hospital-University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Chu Angers | Angers, France | Recruiting |
| CHU de Lille | Lille, France | Recruiting |
| GH Pitié-Salpêtrière | Paris, France | Recruiting |
| CHRU Strasbourg | Strasbourg, France | Recruiting |
| David Metreveli Medical Centre, Tbilisi | Tbilisi, Georgia | Recruiting |
| Beaumont Hospital Royal College of Surgeons in Ireland (RCSI), Dublin | Dublin, Ireland | Recruiting |
| Azienda Ospedaliero Universitaria di Bologna | Bologna, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma | Roma, Italy | Recruiting |
| Centrum Nowoczesnych Terapii, Dobry Lekarz | Dobry Lekarz, Poland | Recruiting |
| Sahlgrenska University Hospital | Gothenburg, Sweden | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05669950